{"paper_id":"073fe106-7dd5-4ec9-a870-8060c7e7de40","body_text":"5. Pagliano P, Sellitto C, Scarpati G, Ascione T, Conti V, Franci G, et al. An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19). Expert Opin Drug Discov 2022;17:9-18.\n6. Akinci E, Cha M, Lin L, Yeo G, Hamilton MC, Donahue CJ, et al. Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics. bioRxiv [Preprint] 2020 Aug 28.\nhttps://doi.org/10.1101/2020.08.27.270819\n8. Govahi A, Nasr-Esfahani MH, Amjadi F, Mahdevar M, Mehdizadeh R, Mehdizadeh M. Cutting-edge techniques provide insights regarding repeated implantation failure patients. Reprod Biomed Online 2023;46:687-96.\n9. Hamid HY, Zakaria MZ. Embryo implantation: shedding light on the roles of ovarian hormones, cytokines and growth factors in the implantation process. Afr J Biotechnol 2012;11:16297-304.\n12. Atta M, Bakery A, Adel M, Fadl A. Developmental toxicity induced by prenatal exposure to remdesivir in pregnant female rats and their offspring. Egypt Acad J Biol Sci B Zool 2024;16:105-20.\n19. Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol 2011;210:5-14.\n20. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, et al. Molecular cues to implantation. Endocr Rev 2004;25:341-73.\n21. Lessey BA. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003;68:809-15.\n23. Basak S, Dhar R, Das C. Steroids modulate the expression of alpha4 integrin in mouse blastocysts and uterus during implantation. Biol Reprod 2002;66:1784-9.\n24. Demir R, Yaba A, Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem 2010;112:203-14.\n25. Abd ElFattah LI. Pinopodes. Egypt J Histol 2012;35:633-9.\n26. Robertson SA, O'Connell A, Ramsey A. The effect of interleukin-6 deficiency on implantation, fetal development and parturition in mice. In: Proceeding of the 31st Annual Conference of the Australian Society for Reproductive Biology; 2000 Apr 26-30; Canberra, Australia.\n27. Hinduja I, Pathare AD, Zaveri K, Hinduja I. Immunological approach of personalized treatment for recurrent implantation failure patients undergoing IVF. Glob J Reprod Med 2018;5:65-7.\n28. Salama KM, Alloush MK, Al Hussini RM. Are the cytokines TNF alpha and IL 1beta early predictors of embryo implantation?: cross sectional study. J Reprod Immunol 2020;137:102618.\n30. Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA. Macrophages regulate expression of a1,2-fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod 2012;18:204-15.\n31. Jasper MJ, Care AS, Sullivan B, Ingman WV, Aplin JD, Robertson SA. Macrophage-derived LIF and IL1B regulate alpha(1,2)fucosyltransferase 2 (Fut2) expression in mouse uterine epithelial cells during early pregnancy. Biol Reprod 2011;84:179-88.\n32. Robertson SA, Moldenhauer LM. Immunological determinants of implantation success. Int J Dev Biol 2014;58:205-17.\n33. Cohen M, Meisser A, Haenggeli L, Bischof P. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 2006;12:225-32.\n35. Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999;5:252-60.","source_license":"public-domain-us","license_restricted":false}